Thymic dendritic cells express inducible nitric oxide synthase and generate nitre oxide in response to self- and alloantigens

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4649-4658

  Aiello, Sistiana ^a   Noris, Marina ^a   Piccinini, Giampiero ^a   Tomasoni, Susanna ^a   Casiraghi, Federica ^a   Bonazzola, Samantha ^a   Mister, Marilena ^a   Sayegh, Mohamed H ^b   Remuzzi, Giuseppe ^a,c  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYMOCYTE;

EID: 0034192110     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4649     Document Type: Article

References (77)

1. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require dedicated antigen-presenting cell? Nature 338:74.
2. Khoury, S. J., L. Gallon, W. Chert, K. Betres, M. E. Russel, W. W. Hancock, C. B. Carpenter, M. H. Sayegh, and H. L. Weiner. 1995. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182:357.
3. Remuzzi, G., and M. Perico. 1995. Immunotolerance: from new knowledge of mechanisms of self-tolerance to future perspectives for induction of renal transplant tolerance. Exp. Nephrol. 3:319.
4. Naji, A. 1996. Induction of tolerance by intrathymic inoculation of alloantigen. Curr. Opin. Immunol. 8:704.
5. Fiedor, P., M.-X. Jin, M. A. Hardy, and S. F. Oluwole, 1997. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient. Transplantation 63:279.
6. Oluwole, S. F., N. C. Chowdhury, M.-X. Jin, and M. A. Hardy. 1993, Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation 56-1523.
7. Sayegh, M. H., N. Perico, O. Imberti, W. W. Hancock, C. B. Carpenter, and G. Remuzzi. 1993. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 56:461.
8. Remuzzi, G., M. Rossini, O. Imberti, and N. Perico. 1991. Kidney graft survival in rats without immunosuppressanls after intrathymic glomerular transplantation. Lancet 337:750.
9. 2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides. J. Exp. Med. 180:1967.
10. Saito, T., and N. Watanabe. 1998. Positive and negative thymocyte selection. Crit. Rev. Immunol. 18:359.
11. Sospedra, M., X. Ferrer-Francesch, O. Dominguez, M. Juan, M. Foz-Sala, and R. Pujol-Borrell. 1998. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol. 161:5918.
12. Sebza, E., V. A. Wallace, J. Mayer, R. S. M. Yeung, T. W. Mak, and P. S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615.
13. Sprent, J., and S. R. Webb. 1995. Intrathymic and extrathymic clonal deletion of T cells. Curr. Opin. Immunol. 7:196.
14. Chen, W., S. Issazadeh, M. H. Sayegh, and S. J. Khoury. 1997. In vivo mechanism of acquired tolerance. Cell Immunol 179:165.
15. Fluck, N. C., N. D. Jones, A. L. Mellor, P. J. Morris, and K. J. Wood. 1997. Thymic events following intrathymic injection of alloantigen elucidated using TCR transgenic mice. In Proceedings of XVI International Congress of Transplantation Society August 25-30, 1996. Barcelona, Spain.
16. Chen, W., M. H. Sayegh, and S. J. Khoury. 1998. Mechanism of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J. Immunol. 160:1504.
17. + thymocytes. J. Immunol 152:3254.
18. Ardavin, C. 1997. Thymic dendritic cells. Immunol. Today 18:350.
19. Broecker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med 185:541.
20. Guery, J. C., and L. Adorini. 1995. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 154:536.
21. Stockinger, B., and B. Hausmann. 1994. Functional recognition of in vivo processed self antigen. Int. Immunol. 6:247.
22. Muller, P., J. Shumacher, and B. A. Kyewski. 1993. Half life of antigen/major histocompatibility complex class H complexes in vivo: intra-and interorgan variations. Eur. J. Immunol. 23:3203.
23. Fehsel, K., K. D. Kroncke, K. L. Meyer, H. Huber, V. Wahn, and V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol 155:2858.
24. Tai, X-G., K., Toyo-oka, N. Yamamoto, Y. Yashiro, J. Mu, T. Hamaoka, and H. Fujiwara. 1997. Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes. J. Immunol. 158:4696.
25. Lu, L., C. A. Bonham, F. G. Chambers, S. C. Watkins, R. A. Hoffman, R. L. Simmons, and A. W. Thomson. 1996. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. J. Immunol. 157:3577.
26. Chao, N. J., L. Timmerman, H. O. McDevitt, and C. O. Jacob. 1989. Molecular characterization of MHC class II antigens (β1 domain) in the BB diabetes-prone and resistant rat. Immunogenetics 29:231.
27. Banuls, M. P., A. Alvarez, I. Ferrero, A. Zapata, and C. Ardavin. 1993. Cell-surface marker analysis of rat thymic dendritic cells. Immunology 79:298.
28. Crowley, M., K. Inaba, M. Witmer-Pack, and R. M. Steinman. 1989. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol. 118:108.
29. Jenkinson, E. J., G. Anderson, and J. J. T. Owen. 1992. Studies on T cell maturation on defined thymic stromal cell population in vitro. J. Exp. Med. 176:845.
30. 2+-dependent mechanism. J. Exp. Med. 186:467.
31. Gavrielli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
32. King, L. B., M. S. Vacchio, R. Hunzjker, D. H, Margulies, and J. D, Ashwell. 1995. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 5:647.
33. Aiello, S., M. Noris, M. Todeschini, S. Zappella, C. Foglieni, A. Benigni, D. Corna, C. Zoja, D. Cavallotti, and G. Remuzzi. 1997. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 52:171.
34. Vodovotz, Y., D. Russell, Q.-W. Xie, C. Bogdan, and C. Nathan, 1995. Vescicle membrane association of nitric oxide synthase in primary mouse macrophages. J. Immunol 154:2914.
35. Noris, M., A. Benigni, P. Boccardo, S. Aiello, F. Gaspari, M. Todeschini, M. Figliuzzi, and G. Remuzzi. 1993. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int. 44: 445.
36. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
37. Witmer-Pack, M. D., J. Valinsky, W. Olivier, and R. M. Steinman. 1988. Quantitation of surface antigens on cultured murine epidermal Langherans cells: rapid and selective increase in the level of surface MHC products. J. Invest. Dermatol. 90:387.
38. Puré, E., K. Inaba, M. T. Crowley, L. Tardelli, M. D. Witmer-Pack, G. Ruberti, G. Fathman, and R. M. Steinman. 1990. Antigen processing by epidermal Langherans cells correlates with the level of biosynthesis of major histocompalibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172: 1459.
39. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibilily complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
40. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous protein antigens on major histocompatibility complex class 1 molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594.
41. Wibo, M., and B. Poole. 1974. Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B. J. Cell Biol. 63:430.
42. Ziegler, H. K., and E. R. Unanue. 1982. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation T cells. Proc Natl. Acad. Sci. USA 79:175.
43. Lippincott-Schwartz, J., J. G. Donaldson, A. Schweizer, E. G. Berger, H.-P. Haun, L. C. Yuan, and R. D. Klausner. 1990. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60:821.
44. Griffin, J. P., R. Chu, and C. V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158:1523.
45. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723.
46. Adorini, L., J. Moreno, F. Momburg, G. J. Hammerling, J.-C. Guery, A. Valli, and S. Fuchs. 1991. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 174:945.
47. Haddad, I. Y., J. P. Crow, P. Hu, Y. Ye, J. Beckman, and S. Matalon. 1994. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 267:L242.
48. Marietta, M. A. 1994. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78:927.
49. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell 78:915.
50. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N Engl. J. Med. 329:2002.
51. Chen-Woan, M., C. P. Delaney, V. Fournier, Y. Wakizaka, N. Murase, J. Fung, T. E. Starzl, and A. J. Demetris. 1996. In vitro characterization of rat bone marrow-derived dendritic cells and their precursors. J. Leukocyte Biol. 59:196.
52. Hart, D. N. J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
53. Volkmann, A., T. Zal, and B. Stockinger. 1997. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol. 158:693.
54. Vremec, D., M. Zorbas, R. Scollay, D. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.
55. Bancherau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
56. + T cells. J. Exp. Med 185:2133.
57. Mazda, O., Y. Watanabe, J.-I. Gyotoku, and Y. Katsura. 1991. Requirement of dendritic cells and B cells in the clonal deletion of Mis-reactive T cells in the thymus. J. Exp. Med. 173:539.
58. Davidson, H. W., P. A. Reid, A. Lanzavecchia, and C. Watts. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105.
59. Sayegh, M. H., S. J. Khoury, W. W. Hancock, H. L. Weiner, and C. B. Carpenter. 1992. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl. Acad. Sci. USA 89:7762.
60. Benichou, G., P. A. Takizawa, P. T. HO, C. C. Killio, M. McMillan, and E. E. Sercarz. 1990. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172:1341.
61. Nuchtern, J. G., W. E. Biddison, and D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74.
62. Olson, C. A., L. C. Williams, E. McLaughlin-Taylor, and M. McMillan. 1989. Creation of H-2 class I epitopes using synthetic pcplides: recognition by alloreactive cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 86:1031.
63. Parham, P., C. Clayberger, L. Zorn, D. S. Ludwig, G. K. Schoolnik, and A. M. Krensky. 1987. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA-A2. Nature 325:625.
64. Sayegh, M. H., N. Perico, L. Gallon, O. Imberti, W. W. Hancock, G. Remuzzi, and C. B. Carpenter. 1994. Mechanism of acquired thymic unresponsiveness to renal allografts. Transplantation 58:125
65. Amsen, D., and A. M. Kruisbeek. 1998. Thymocyte selection: not by TCR alone. Immunol. Rev. 165:209.
66. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080.
67. Chlichlia, K., M. E. Peter, M. Rocha, C. Scaffidi, M. Bucur, P. H. Krammer, V. Schirrmacher, and V. Umansky. 1998. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fis-)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood 91:4311.
68. Takeda, Y., M. Tashima, A. Takahashi, T. Uchiyama, and T. Okazaki. 1999. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J. Biol. Chem. 274:10654.
69. McDaniel, M. L., J. A. Corbett, G. Kwon, and J. R. Hill. 1997. A role for nitric oxide and other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunction and destruction. Adv. Exp. Med. Biol. 426:313.
70. Glogkzin, S., A. von Knethen, M. Scheffner, and B. Brune. 1999. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:19581.
71. Stadler, J., R. Dochoa Curran, J.B., B. G. Harbrecht, and R. A. Hoffman. 1991. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch. Surg. 126:186.
72. Nguyen, T., D. Brunson, C. L. Crespi, B. W. Penman, J. S. Wishnok, and S. R. Tannenbaum. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89:3030.
73. Kim, Y-M., T. H. Kim, D. W. Seol, R. V. Talanian, and T. R. Billiar. 1998. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 273:31437.
74. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide-produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reaction. Cell 79:1137.
75. Kim, Y.-M., C. A. Bombeck, and T. R. Billiar. 1999. Nitric oxide as bifunctional regulator of apoptosis. Circ. Res. 84:253.
76. Li, J., C. A. Bombeck, S. Yang, Y.-M. Kim, and T. R. Billiar. 1999. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J. Biol. Chem. 274:17325.
77. Cobb, J. P., R. S. Hotchkiss, P. E. Swanson, K. Chang, Y. Qiu, V. E. Laubach, I. E. Karl, and T. G. Buchman. 1999. Inducible nitric oxide synthase (iNOS) gene deficiency increases mortality of sepsis in mice. Surgery 126:438.